CCG
BIIB icon

Cypress Capital Group’s Biogen BIIB Stock Holding History

Cypress Capital Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-999
Closed -$278K – 302
2023
Q1 		$278K Buy
999
+100
+11% +$27.7K 0.04% 254
2022
Q4 		$249K Buy
+899
New +$254K 0.04% 266
2021
Q4 		– Sell
-888
Closed -$251K – 323
2021
Q3 		$251K Sell
888
-2,444
-73% -$801K 0.03% 249
2021
Q2 		$1.15M Sell
3,332
-757
-19% -$229K 0.16% 127
2021
Q1 		$1.14M Buy
4,089
+548
+15% +$148K 0.16% 126
2020
Q4 		$867K Sell
3,541
-904
-20% -$233K 0.13% 138
2020
Q3 		$1.26M Buy
4,445
+101
+2% +$28.2K 0.21% 110
2020
Q2 		$1.16M Buy
4,344
+2,717
+167% +$817K 0.21% 106
2020
Q1 		$514K Buy
1,627
+51
+3% +$15.5K 0.12% 122
2019
Q4 		$468K Sell
1,576
-337
-18% -$93.5K 0.08% 154
2019
Q3 		$446K Buy
1,913
+432
+29% +$101K 0.09% 162
2019
Q2 		$347K Sell
1,481
-990
-40% -$229K 0.07% 182
2019
Q1 		$584K Sell
2,471
-179
-7% -$56.4K 0.12% 143
2018
Q4 		$797K Buy
2,650
+445
+20% +$142K 0.18% 111
2018
Q3 		$779K Buy
2,205
+340
+18% +$117K 0.15% 128
2018
Q2 		$542K Buy
1,865
+105
+6% +$29.5K 0.11% 150
2018
Q1 		$482K Buy
1,760
+319
+22% +$99K 0.1% 153
2017
Q4 		$459K Buy
1,441
+33
+2% +$10.6K 0.1% 158
2017
Q3 		$441K Buy
1,408
+639
+83% +$189K 0.09% 157
2017
Q2 		$209K Buy
+769
New +$203K 0.05% 198

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cypress Capital Group's BIIB Position: Q2 2023 in Review

Cypress Capital Group sold out of Biogen (BIIB) in Q2 2023, closing a stake of 999 shares — an estimated $278K sold.

Cypress Capital Group first reported a position in BIIB in Q2 2017 and held it in 20 quarters. The position peaked at $1.26M in Q3 2020. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Cypress Capital Group reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Cypress Capital Group sold 999 Biogen shares in Q2 2023, an estimated $278K.
  • Cypress Capital Group first reported a position in Biogen in Q2 2017 and held it in 20 quarters.
  • Cypress Capital Group's Biogen position peaked at $1.26M in Q3 2020.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Cypress Capital Group's 13F filing for Q2 2023, filed 26 Jul 2023.